Matsubayashi Y, Yoshida A, Suganami H, Oe M, et al. Association of estimated plasma volume and weight loss after long-term administration and subsequent discontinuation of the sodium-glucose cotransporter-2 inhibitor tofogliflozin. Diabetes Obes Metab 2021;23:1660-1665.
PMID: 33769665